5Li R, Zhang QF, Yang DZ, et al. Prevalence of polycystic ovary syn- drome in women in China: a large community-based study [ J ]. Hum Reprod ,2013,28 ( 9 ) : 2562 -2569.
6Homburg R. Androgen circle of polycystic ovary syndrome [ J ]. Hum Reprod, 2009,24 (7) : 1548-1555.
7Butt Solorzano CM, Belier JP, Abshire MY, et al. Neuroendocrine dys- function in polyeystic ovary syndrome [ J ]. Steroids, 2012,77 ( 4 ) :332- 337.
8Diamanti-Kandarakis E, Piouka A, Livadas S, et al. Antimullerian hor- mone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome [ J ]. Eur J Endocrinol, 2009, 160(5) :847-853.
9Nybacka A, Carlstom K, Fabri F, et al. Serum antimullerian hormone in response to dietary management and/or physical exercise in over- weight/obese women with polycystic ovary syndrome:secondary analy- sis of a randomized controlled trial [ J ]. Fertil Steril, 2013,100 ( 4 ) : 1096-1102.
10Ehrlich S, Williams PL, Missmer SA, et al. Urinary bisphenol A con- centrations and early reproductive health outcomes among women un- dergoing IVF[ J ]. Hum Reprod ,2012,27 ( 12 ) :3583-3592.
